Download PDF
Clin Colon Rectal Surg 2020; 33(02): 098-108
DOI: 10.1055/s-0040-1701234
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Hospital Infection Control: Clostridioides difficile

Nicholas A. Turner
1   Duke University Medical Center, Department of Medicine, Division of Infectious Diseases, Durham, North Carolina
2   Duke Center for Antimicrobial Stewardship and Infection Prevention, Durham, North Carolina
,
Deverick J. Anderson
1   Duke University Medical Center, Department of Medicine, Division of Infectious Diseases, Durham, North Carolina
2   Duke Center for Antimicrobial Stewardship and Infection Prevention, Durham, North Carolina
› Author Affiliations
Further Information

Publication History

Publication Date:
25 February 2020 (online)

    Permissions and Reprints

Abstract

Clostridioides difficile remains a leading cause of healthcare-associated infection. Efforts at C. difficile prevention have been hampered by an increasingly complex understanding of transmission patterns and a high degree of heterogeneity among existing studies. Effective prevention of C. difficile infection requires multimodal interventions, including contact precautions, hand hygiene with soap and water, effective environmental cleaning, use of sporicidal cleaning agents, and antimicrobial stewardship. Roles for probiotics, avoidance of proton pump inhibitors, and isolation of asymptomatic carriers remain poorly defined.

Keywords

Clostridioides difficile - infection control - infection prevention

Support Information

Nicholas Turner was supported in part by an Antibacterial Resistance Leadership Group fellowship (National Institute of Allergy and Infectious Diseases UM1AI104681). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.


 

  • References

  • 1 Lessa FC, Mu Y, Bamberg WM. , et al. Burden of Clostridium difficile infection in the United States. N Engl J Med 2015; 372 (09) 825-834
    CrossrefPubMedGoogle Scholar
  • 2 Chitnis AS, Holzbauer SM, Belflower RM. , et al. Epidemiology of community-associated Clostridium difficile infection, 2009 through 2011. JAMA Intern Med 2013; 173 (14) 1359-1367
    CrossrefPubMedGoogle Scholar
  • 3 Eyre DW, Cule ML, Wilson DJ. , et al. Diverse sources of C. difficile infection identified on whole-genome sequencing. N Engl J Med 2013; 369 (13) 1195-1205
    CrossrefPubMedGoogle Scholar
  • 4 Dubberke E. Strategies for prevention of Clostridium difficile infection. J Hosp Med 2012; 7 (Suppl. 03) S14-S17
    PubMedGoogle Scholar
  • 5 Zacharioudakis IM, Zervou FN, Pliakos EE, Ziakas PD, Mylonakis E. Colonization with toxinogenic C. difficile upon hospital admission, and risk of infection: a systematic review and meta-analysis. Am J Gastroenterol 2015; 110 (03) 381-390 , quiz 391
    CrossrefPubMedGoogle Scholar
  • 6 Kubota H, Makino H, Gawad A. , et al. Longitudinal investigation of carriage rates, counts, and genotypes of toxigenic Clostridium difficile in early infancy. Appl Environ Microbiol 2016; 82 (19) 5806-5814
    CrossrefPubMedGoogle Scholar
  • 7 He M, Miyajima F, Roberts P. , et al. Emergence and global spread of epidemic healthcare-associated Clostridium difficile . Nat Genet 2013; 45 (01) 109-113
    CrossrefPubMedGoogle Scholar
  • 8 McDonald LC, Killgore GE, Thompson A. , et al. An epidemic, toxin gene-variant strain of Clostridium difficile . N Engl J Med 2005; 353 (23) 2433-2441
    CrossrefPubMedGoogle Scholar
  • 9 Warny M, Pepin J, Fang A. , et al. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet 2005; 366 (9491): 1079-1084
    CrossrefPubMedGoogle Scholar
  • 10 Freeman J, Bauer MP, Baines SD. , et al. The changing epidemiology of Clostridium difficile infections. Clin Microbiol Rev 2010; 23 (03) 529-549
    CrossrefPubMedGoogle Scholar
  • 11 Bauer MP, Notermans DW, van Benthem BH. , et al; ECDIS Study Group. Clostridium difficile infection in Europe: a hospital-based survey. Lancet 2011; 377 (9759): 63-73
    CrossrefPubMedGoogle Scholar
  • 12 Evans CT, Safdar N. Current trends in the epidemiology and outcomes of Clostridium difficile infection. Clin Infect Dis 2015; 60 (Suppl. 02) S66-S71
    CrossrefPubMedGoogle Scholar
  • 13 Magill SS, Edwards JR, Bamberg W. , et al; Emerging Infections Program Healthcare-Associated Infections and Antimicrobial Use Prevalence Survey Team. Multistate point-prevalence survey of health care-associated infections. N Engl J Med 2014; 370 (13) 1198-1208
    CrossrefPubMedGoogle Scholar
  • 14 Miller BA, Chen LF, Sexton DJ, Anderson DJ. Comparison of the burdens of hospital-onset, healthcare facility-associated Clostridium difficile infection and of healthcare-associated infection due to methicillin-resistant Staphylococcus aureus in community hospitals. Infect Control Hosp Epidemiol 2011; 32 (04) 387-390
    CrossrefPubMedGoogle Scholar
  • 15 Carignan A, Allard C, Pépin J, Cossette B, Nault V, Valiquette L. Risk of Clostridium difficile infection after perioperative antibacterial prophylaxis before and during an outbreak of infection due to a hypervirulent strain. Clin Infect Dis 2008; 46 (12) 1838-1843
    CrossrefPubMedGoogle Scholar
  • 16 Zerey M, Paton BL, Lincourt AE, Gersin KS, Kercher KW, Heniford BT. The burden of Clostridium difficile in surgical patients in the United States. Surg Infect (Larchmt) 2007; 8 (06) 557-566
    CrossrefPubMedGoogle Scholar
  • 17 Li X, Wilson M, Nylander W, Smith T, Lynn M, Gunnar W. Analysis of morbidity and mortality outcomes in postoperative Clostridium difficile infection in the veterans health administration. JAMA Surg 2016; 151 (04) 314-322
    CrossrefPubMedGoogle Scholar
  • 18 Poeran J, Mazumdar M, Rasul R. , et al. Antibiotic prophylaxis and risk of Clostridium difficile infection after coronary artery bypass graft surgery. J Thorac Cardiovasc Surg 2016; 151 (02) 589-97.e2
    CrossrefPubMedGoogle Scholar
  • 19 Abdelsattar ZM, Krapohl G, Alrahmani L. , et al. Postoperative burden of hospital-acquired Clostridium difficile infection. Infect Control Hosp Epidemiol 2015; 36 (01) 40-46
    CrossrefPubMedGoogle Scholar
  • 20 Vogel TR, Dombrovskiy VY, Lowry SF. Impact of infectious complications after elective surgery on hospital readmission and late deaths in the U.S. Medicare population. Surg Infect (Larchmt) 2012; 13 (05) 307-311
    CrossrefPubMedGoogle Scholar
  • 21 Shaughnessy MK, Bobr A, Kuskowski MA. , et al. Environmental contamination in households of patients with recurrent Clostridium difficile infection. Appl Environ Microbiol 2016; 82 (09) 2686-2692
    CrossrefPubMedGoogle Scholar
  • 22 Dubberke ER, Reske KA, Noble-Wang J. , et al. Prevalence of Clostridium difficile environmental contamination and strain variability in multiple health care facilities. Am J Infect Control 2007; 35 (05) 315-318
    CrossrefPubMedGoogle Scholar
  • 23 Sethi AK, Al-Nassir WN, Nerandzic MM, Bobulsky GS, Donskey CJ. Persistence of skin contamination and environmental shedding of Clostridium difficile during and after treatment of C. difficile infection. Infect Control Hosp Epidemiol 2010; 31 (01) 21-27
    CrossrefPubMedGoogle Scholar
  • 24 Guerrero DM, Becker JC, Eckstein EC. , et al. Asymptomatic carriage of toxigenic Clostridium difficile by hospitalized patients. J Hosp Infect 2013; 85 (02) 155-158
    CrossrefPubMedGoogle Scholar
  • 25 Riggs MM, Sethi AK, Zabarsky TF, Eckstein EC, Jump RL, Donskey CJ. Asymptomatic carriers are a potential source for transmission of epidemic and nonepidemic Clostridium difficile strains among long-term care facility residents. Clin Infect Dis 2007; 45 (08) 992-998
    CrossrefPubMedGoogle Scholar
  • 26 Shrestha SK, Sunkesula VC, Kundrapu S, Tomas ME, Nerandzic MM, Donskey CJ. Acquisition of Clostridium difficile on hands of healthcare personnel caring for patients with resolved C. difficile infection. Infect Control Hosp Epidemiol 2016; 37 (04) 475-477
    CrossrefPubMedGoogle Scholar
  • 27 Jullian-Desayes I, Landelle C, Mallaret MR, Brun-Buisson C, Barbut F. Clostridium difficile contamination of health care workers' hands and its potential contribution to the spread of infection: review of the literature. Am J Infect Control 2017; 45 (01) 51-58
    CrossrefPubMedGoogle Scholar
  • 28 Landelle C, Verachten M, Legrand P, Girou E, Barbut F, Brun-Buisson C. Contamination of healthcare workers' hands with Clostridium difficile spores after caring for patients with C. difficile infection. Infect Control Hosp Epidemiol 2014; 35 (01) 10-15
    CrossrefPubMedGoogle Scholar
  • 29 Oughton MT, Loo VG, Dendukuri N, Fenn S, Libman MD. Hand hygiene with soap and water is superior to alcohol rub and antiseptic wipes for removal of Clostridium difficile . Infect Control Hosp Epidemiol 2009; 30 (10) 939-944
    CrossrefPubMedGoogle Scholar
  • 30 Kundrapu S, Sunkesula V, Jury I, Deshpande A, Donskey CJ. A randomized trial of soap and water hand wash versus alcohol hand rub for removal of Clostridium difficile spores from hands of patients. Infect Control Hosp Epidemiol 2014; 35 (02) 204-206
    CrossrefPubMedGoogle Scholar
  • 31 Jabbar U, Leischner J, Kasper D. , et al. Effectiveness of alcohol-based hand rubs for removal of Clostridium difficile spores from hands. Infect Control Hosp Epidemiol 2010; 31 (06) 565-570
    CrossrefPubMedGoogle Scholar
  • 32 Pokrywka M, Buraczewski M, Frank D. , et al. Can improving patient hand hygiene impact Clostridium difficile infection events at an academic medical center?. Am J Infect Control 2017; 45 (09) 959-963
    CrossrefPubMedGoogle Scholar
  • 33 Barker AK, Zellmer C, Tischendorf J. , et al. On the hands of patients with Clostridium difficile: a study of spore prevalence and the effect of hand hygiene on C. difficile removal. Am J Infect Control 2017; 45 (10) 1154-1156
    CrossrefPubMedGoogle Scholar
  • 34 Kaier K, Hagist C, Frank U, Conrad A, Meyer E. Two time-series analyses of the impact of antibiotic consumption and alcohol-based hand disinfection on the incidences of nosocomial methicillin-resistant Staphylococcus aureus infection and Clostridium difficile infection. Infect Control Hosp Epidemiol 2009; 30 (04) 346-353
    CrossrefPubMedGoogle Scholar
  • 35 Vernaz N, Sax H, Pittet D, Bonnabry P, Schrenzel J, Harbarth S. Temporal effects of antibiotic use and hand rub consumption on the incidence of MRSA and Clostridium difficile . J Antimicrob Chemother 2008; 62 (03) 601-607
    CrossrefPubMedGoogle Scholar
  • 36 Boyce JM, Guercia KA, Sullivan L. , et al. Prospective cluster controlled crossover trial to compare the impact of an improved hydrogen peroxide disinfectant and a quaternary ammonium-based disinfectant on surface contamination and health care outcomes. Am J Infect Control 2017; 45 (09) 1006-1010
    CrossrefPubMedGoogle Scholar
  • 37 Stone SP, Fuller C, Savage J. , et al. Evaluation of the national Cleanyourhands campaign to reduce Staphylococcus aureus bacteraemia and Clostridium difficile infection in hospitals in England and Wales by improved hand hygiene: four year, prospective, ecological, interrupted time series study. BMJ 2012; 344: e3005
    CrossrefPubMedGoogle Scholar
  • 38 Deyneko A, Cordeiro F, Berlin L, Ben-David D, Perna S, Longtin Y. Impact of sink location on hand hygiene compliance after care of patients with Clostridium difficile infection: a cross-sectional study. BMC Infect Dis 2016; 16: 203
    CrossrefPubMedGoogle Scholar
  • 39 Deschênes P, Chano F, Dionne LL, Pittet D, Longtin Y. Efficacy of the World Health Organization-recommended handwashing technique and a modified washing technique to remove Clostridium difficile from hands. Am J Infect Control 2017; 45 (08) 844-848
    CrossrefPubMedGoogle Scholar
  • 40 Tomas ME, Nerandzic MM, Cadnum JL. , et al. A novel, sporicidal formulation of ethanol for glove decontamination to prevent Clostridium difficile hand contamination during glove removal. Infect Control Hosp Epidemiol 2016; 37 (03) 337-339
    CrossrefPubMedGoogle Scholar
  • 41 Nerandzic MM, Sunkesula VC, , C TS, Setlow P, Donskey CJ. Unlocking the sporicidal potential of ethanol: induced sporicidal activity of ethanol against Clostridium difficile and Bacillus spores under altered physical and chemical conditions. PLoS One 2015; 10 (07) e0132805
    CrossrefPubMedGoogle Scholar
  • 42 Guerrero DM, Nerandzic MM, Jury LA, Jinno S, Chang S, Donskey CJ. Acquisition of spores on gloved hands after contact with the skin of patients with Clostridium difficile infection and with environmental surfaces in their rooms. Am J Infect Control 2012; 40 (06) 556-558
    CrossrefPubMedGoogle Scholar
  • 43 Weber DJ, Rutala WA, Miller MB, Huslage K, Sickbert-Bennett E. Role of hospital surfaces in the transmission of emerging health care-associated pathogens: norovirus, Clostridium difficile, and Acinetobacter species . Am J Infect Control 2010; 38 (05) (Suppl. 01) S25-S33
    CrossrefPubMedGoogle Scholar
  • 44 Bobulsky GS, Al-Nassir WN, Riggs MM, Sethi AK, Donskey CJ. Clostridium difficile skin contamination in patients with C. difficile-associated disease. Clin Infect Dis 2008; 46 (03) 447-450
    CrossrefPubMedGoogle Scholar
  • 45 Teltsch DY, Hanley J, Loo V, Goldberg P, Gursahaney A, Buckeridge DL. Infection acquisition following intensive care unit room privatization. Arch Intern Med 2011; 171 (01) 32-38
    PubMedGoogle Scholar
  • 46 Widmer AF, Frei R, Erb S. , et al. Transmissibility of Clostridium difficile without contact isolation: results from a prospective observational study with 451 patients. Clin Infect Dis 2017; 64 (04) 393-400
    PubMedGoogle Scholar
  • 47 Brown K, Valenta K, Fisman D, Simor A, Daneman N. Hospital ward antibiotic prescribing and the risks of Clostridium difficile infection. JAMA Intern Med 2015; 175 (04) 626-633
    CrossrefPubMedGoogle Scholar
  • 48 Deshpande A, Pasupuleti V, Thota P. , et al. Community-associated Clostridium difficile infection and antibiotics: a meta-analysis. J Antimicrob Chemother 2013; 68 (09) 1951-1961
    CrossrefPubMedGoogle Scholar
  • 49 Kundrapu S, Sunkesula VC, Jury LA. , et al. Do piperacillin/tazobactam and other antibiotics with inhibitory activity against Clostridium difficile reduce the risk for acquisition of C. difficile colonization?. BMC Infect Dis 2016; 16: 159
    CrossrefPubMedGoogle Scholar
  • 50 Balch A, Wendelboe AM, Vesely SK, Bratzler DW. Antibiotic prophylaxis for surgical site infections as a risk factor for infection with Clostridium difficile . PLoS One 2017; 12 (06) e0179117
    CrossrefPubMedGoogle Scholar
  • 51 Wenisch C, Parschalk B, Hasenhündl M, Hirschl AM, Graninger W. Comparison of vancomycin, teicoplanin, metronidazole, and fusidic acid for the treatment of Clostridium difficile-associated diarrhea. Clin Infect Dis 1996; 22 (05) 813-818
    CrossrefPubMedGoogle Scholar
  • 52 DiDiodato G, McArthur L. Evaluating the effectiveness of an antimicrobial stewardship program on reducing the incidence rate of healthcare-associated Clostridium difficile infection: a non-randomized, stepped wedge, single-site, observational study. PLoS One 2016; 11 (06) e0157671
    CrossrefPubMedGoogle Scholar
  • 53 Patton A, Davey P, Harbarth S, Nathwani D, Sneddon J, Marwick CA. Impact of antimicrobial stewardship interventions on Clostridium difficile infection and clinical outcomes: segmented regression analyses. J Antimicrob Chemother 2018; 73 (02) 517-526
    CrossrefPubMedGoogle Scholar
  • 54 Baur D, Gladstone BP, Burkert F. , et al. Effect of antibiotic stewardship on the incidence of infection and colonisation with antibiotic-resistant bacteria and Clostridium difficile infection: a systematic review and meta-analysis. Lancet Infect Dis 2017; 17 (09) 990-1001
    CrossrefPubMedGoogle Scholar
  • 55 Feazel LM, Malhotra A, Perencevich EN, Kaboli P, Diekema DJ, Schweizer ML. Effect of antibiotic stewardship programmes on Clostridium difficile incidence: a systematic review and meta-analysis. J Antimicrob Chemother 2014; 69 (07) 1748-1754
    CrossrefPubMedGoogle Scholar
  • 56 Walker H, Patton A, Bayne G. , et al. Reduction in post-operative acute kidney injury following a change in antibiotic prophylaxis policy for orthopaedic surgery: an observational study. J Antimicrob Chemother 2016; 71 (09) 2598-2605
    CrossrefPubMedGoogle Scholar
  • 57 Blocker O, Abdulkadir U, Roberts P. Clostridium difficile-associated diarrhoea in primary joint arthroplasty in Aneurin Bevan University Health Board South. Ann R Coll Surg Engl 2016; 98 (03) 222-225
    CrossrefPubMedGoogle Scholar
  • 58 Al-Obaydi W, Smith CD, Foguet P. Changing prophylactic antibiotic protocol for reducing Clostridium difficile-associated diarrhoeal infections. J Orthop Surg (Hong Kong) 2010; 18 (03) 320-323
    CrossrefPubMedGoogle Scholar
  • 59 Bratzler DW, Dellinger EP, Olsen KM. , et al; American Society of Health-System Pharmacists (ASHP); Infectious Diseases Society of America (IDSA); Surgical Infection Society (SIS); Society for Healthcare Epidemiology of America (SHEA). Clinical practice guidelines for antimicrobial prophylaxis in surgery. Surg Infect (Larchmt) 2013; 14 (01) 73-156
    CrossrefPubMedGoogle Scholar
  • 60 Macy E, Contreras R. Health care use and serious infection prevalence associated with penicillin “allergy” in hospitalized patients: a cohort study. J Allergy Clin Immunol 2014; 133 (03) 790-796
    CrossrefPubMedGoogle Scholar
  • 61 Vaisman A, McCready J, Hicks S, Powis J. Optimizing preoperative prophylaxis in patients with reported β-lactam allergy: a novel extension of antimicrobial stewardship. J Antimicrob Chemother 2017; 72 (09) 2657-2660
    CrossrefPubMedGoogle Scholar
  • 62 Sigona NS, Steele JM, Miller CD. Impact of a pharmacist-driven beta-lactam allergy interview on inpatient antimicrobial therapy: a pilot project. J Am Pharm Assoc (2003) 2016; 56 (06) 665-669
    CrossrefPubMedGoogle Scholar
  • 63 del Real GA, Rose ME, Ramirez-Atamoros MT. , et al. Penicillin skin testing in patients with a history of beta-lactam allergy. Ann Allergy Asthma Immunol 2007; 98 (04) 355-359
    CrossrefPubMedGoogle Scholar
  • 64 Penicillin Allergy in Antibiotic Resistance Workgroup. Penicillin allergy testing should be performed routinely in patients with self-reported penicillin allergy. J Allergy Clin Immunol Pract 2017; 5 (02) 333-334
    CrossrefPubMedGoogle Scholar
  • 65 Park M, Markus P, Matesic D, Li JT. Safety and effectiveness of a preoperative allergy clinic in decreasing vancomycin use in patients with a history of penicillin allergy. Ann Allergy Asthma Immunol 2006; 97 (05) 681-687
    CrossrefPubMedGoogle Scholar
  • 66 Rimawi RH, Cook PP, Gooch M. , et al. The impact of penicillin skin testing on clinical practice and antimicrobial stewardship. J Hosp Med 2013; 8 (06) 341-345
    CrossrefPubMedGoogle Scholar
  • 67 Blumenthal KG, Ryan EE, Li Y, Lee H, Kuhlen JL, Shenoy ES. The impact of a reported penicillin allergy on surgical site infection risk. Clin Infect Dis 2018; 66 (03) 329-336
    CrossrefPubMedGoogle Scholar
  • 68 Shaughnessy MK, Micielli RL, DePestel DD. , et al. Evaluation of hospital room assignment and acquisition of Clostridium difficile infection. Infect Control Hosp Epidemiol 2011; 32 (03) 201-206
    CrossrefPubMedGoogle Scholar
  • 69 Verity P, Wilcox MH, Fawley W, Parnell P. Prospective evaluation of environmental contamination by Clostridium difficile in isolation side rooms. J Hosp Infect 2001; 49 (03) 204-209
    CrossrefPubMedGoogle Scholar
  • 70 Warrack S, Duster M, Van Hoof S, Schmitz M, Safdar N. Clostridium difficile in a children's hospital: assessment of environmental contamination. Am J Infect Control 2014; 42 (07) 802-804
    CrossrefPubMedGoogle Scholar
  • 71 Orenstein R, Aronhalt KC, McManus Jr JE, Fedraw LA. A targeted strategy to wipe out Clostridium difficile . Infect Control Hosp Epidemiol 2011; 32 (11) 1137-1139
    CrossrefPubMedGoogle Scholar
  • 72 Kaatz GW, Gitlin SD, Schaberg DR. , et al. Acquisition of Clostridium difficile from the hospital environment. Am J Epidemiol 1988; 127 (06) 1289-1294
    CrossrefPubMedGoogle Scholar
  • 73 McMullen KM, Zack J, Coopersmith CM, Kollef M, Dubberke E, Warren DK. Use of hypochlorite solution to decrease rates of Clostridium difficile-associated diarrhea. Infect Control Hosp Epidemiol 2007; 28 (02) 205-207
    CrossrefPubMedGoogle Scholar
  • 74 Zhang A, Nerandzic MM, Kundrapu S, Donskey CJ. Does organic material on hospital surfaces reduce the effectiveness of hypochlorite and UV radiation for disinfection of Clostridium difficile?. Infect Control Hosp Epidemiol 2013; 34 (10) 1106-1108
    CrossrefPubMedGoogle Scholar
  • 75 Cadnum JL, Tomas ME, Sankar T. , et al. Effect of variation in test methods on performance of ultraviolet-C radiation room decontamination. Infect Control Hosp Epidemiol 2016; 37 (05) 555-560
    CrossrefPubMedGoogle Scholar
  • 76 Rutala WA, Gergen MF, Weber DJ. Efficacy of different cleaning and disinfection methods against Clostridium difficile spores: importance of physical removal versus sporicidal inactivation. Infect Control Hosp Epidemiol 2012; 33 (12) 1255-1258
    CrossrefPubMedGoogle Scholar
  • 77 Semret M, Dyachenko A, Ramman-Haddad L, Belzile E, McCusker J. Cleaning the grey zones of hospitals: a prospective, crossover, interventional study. Am J Infect Control 2016; 44 (12) 1582-1588
    CrossrefPubMedGoogle Scholar
  • 78 Guerrero DM, Carling PC, Jury LA, Ponnada S, Nerandzic MM, Donskey CJ. Beyond the Hawthorne effect: reduction of Clostridium difficile environmental contamination through active intervention to improve cleaning practices. Infect Control Hosp Epidemiol 2013; 34 (05) 524-526
    CrossrefPubMedGoogle Scholar
  • 79 Eckstein BC, Adams DA, Eckstein EC. , et al. Reduction of Clostridium difficile and vancomycin-resistant Enterococcus contamination of environmental surfaces after an intervention to improve cleaning methods. BMC Infect Dis 2007; 7: 61
    CrossrefPubMedGoogle Scholar
  • 80 Sitzlar B, Deshpande A, Fertelli D, Kundrapu S, Sethi AK, Donskey CJ. An environmental disinfection odyssey: evaluation of sequential interventions to improve disinfection of Clostridium difficile isolation rooms. Infect Control Hosp Epidemiol 2013; 34 (05) 459-465
    CrossrefPubMedGoogle Scholar
  • 81 Best EL, Parnell P, Thirkell G. , et al. Effectiveness of deep cleaning followed by hydrogen peroxide decontamination during high Clostridium difficile infection incidence. J Hosp Infect 2014; 87 (01) 25-33
    CrossrefPubMedGoogle Scholar
  • 82 Fawley WN, Underwood S, Freeman J. , et al. Efficacy of hospital cleaning agents and germicides against epidemic Clostridium difficile strains. Infect Control Hosp Epidemiol 2007; 28 (08) 920-925
    CrossrefPubMedGoogle Scholar
  • 83 Siani H, Cooper C, Maillard JY. Efficacy of “sporicidal” wipes against Clostridium difficile . Am J Infect Control 2011; 39 (03) 212-218
    CrossrefPubMedGoogle Scholar
  • 84 Barbut F, Menuet D, Verachten M, Girou E. Comparison of the efficacy of a hydrogen peroxide dry-mist disinfection system and sodium hypochlorite solution for eradication of Clostridium difficile spores. Infect Control Hosp Epidemiol 2009; 30 (06) 507-514
    CrossrefPubMedGoogle Scholar
  • 85 Doan L, Forrest H, Fakis A, Craig J, Claxton L, Khare M. Clinical and cost effectiveness of eight disinfection methods for terminal disinfection of hospital isolation rooms contaminated with Clostridium difficile 027. J Hosp Infect 2012; 82 (02) 114-121
    CrossrefPubMedGoogle Scholar
  • 86 Wullt M, Odenholt I, Walder M. Activity of three disinfectants and acidified nitrite against Clostridium difficile spores. Infect Control Hosp Epidemiol 2003; 24 (10) 765-768
    CrossrefPubMedGoogle Scholar
  • 87 Hacek DM, Ogle AM, Fisher A, Robicsek A, Peterson LR. Significant impact of terminal room cleaning with bleach on reducing nosocomial Clostridium difficile . Am J Infect Control 2010; 38 (05) 350-353
    CrossrefPubMedGoogle Scholar
  • 88 Pegues DA, Han J, Gilmar C, McDonnell B, Gaynes S. Impact of ultraviolet germicidal irradiation for no-touch terminal room disinfection on Clostridium difficile infection incidence among hematology-oncology patients. Infect Control Hosp Epidemiol 2017; 38 (01) 39-44
    CrossrefPubMedGoogle Scholar
  • 89 McCord J, Prewitt M, Dyakova E, Mookerjee S, Otter JA. Reduction in Clostridium difficile infection associated with the introduction of hydrogen peroxide vapour automated room disinfection. J Hosp Infect 2016; 94 (02) 185-187
    CrossrefPubMedGoogle Scholar
  • 90 Wong T, Woznow T, Petrie M. , et al. Postdischarge decontamination of MRSA, VRE, and Clostridium difficile isolation rooms using 2 commercially available automated ultraviolet-C-emitting devices. Am J Infect Control 2016; 44 (04) 416-420
    CrossrefPubMedGoogle Scholar
  • 91 Mosci D, Marmo GW, Sciolino L. , et al. Automatic environmental disinfection with hydrogen peroxide and silver ions versus manual environmental disinfection with sodium hypochlorite: a multicentre randomized before-and-after trial. J Hosp Infect 2017; 97 (02) 175-179
    CrossrefPubMedGoogle Scholar
  • 92 Anderson DJ, Gergen MF, Smathers E. , et al. Decontamination of targeted pathogens from patient rooms using an automated ultraviolet-C-emitting device. Infect Control Hosp Epidemiol 2013; 34 (05) 466-471
    CrossrefPubMedGoogle Scholar
  • 93 Anderson DJ, Chen LF, Weber DJ. , et al; CDC Prevention Epicenters Program. Enhanced terminal room disinfection and acquisition and infection caused by multidrug-resistant organisms and Clostridium difficile (the benefits of enhanced terminal room disinfection study): a cluster-randomised, multicentre, crossover study. Lancet 2017; 389 (10071): 805-814
    CrossrefPubMedGoogle Scholar
  • 94 Anderson DJ, Moehring RW, Weber DJ. , et al; CDC Prevention Epicenters Program. Effectiveness of targeted enhanced terminal room disinfection on hospital-wide acquisition and infection with multidrug-resistant organisms and Clostridium difficile: a secondary analysis of a multicentre cluster randomised controlled trial with crossover design (BETR disinfection). Lancet Infect Dis 2018; 18 (08) 845-853
    CrossrefPubMedGoogle Scholar
  • 95 Guerrero DM, Chou C, Jury LA, Nerandzic MM, Cadnum JC, Donskey CJ. Clinical and infection control implications of Clostridium difficile infection with negative enzyme immunoassay for toxin. Clin Infect Dis 2011; 53 (03) 287-290
    CrossrefPubMedGoogle Scholar
  • 96 Grigoras CA, Zervou FN, Zacharioudakis IM, Siettos CI, Mylonakis E. Isolation of C. difficile carriers alone and as part of a bundle approach for the prevention of Clostridium difficile infection (CDI): a mathematical model based on clinical study data. PLoS One 2016; 11 (06) e0156577
    CrossrefPubMedGoogle Scholar
  • 97 Eyre DW, Griffiths D, Vaughan A. , et al. Asymptomatic Clostridium difficile colonisation and onward transmission. PLoS One 2013; 8 (11) e78445
    CrossrefPubMedGoogle Scholar
  • 98 Curry SR, Muto CA, Schlackman JL. , et al. Use of multilocus variable number of tandem repeats analysis genotyping to determine the role of asymptomatic carriers in Clostridium difficile transmission. Clin Infect Dis 2013; 57 (08) 1094-1102
    CrossrefPubMedGoogle Scholar
  • 99 Longtin Y, Paquet-Bolduc B, Gilca R. , et al. Effect of detecting and isolating Clostridium difficile carriers at hospital admission on the incidence of C difficile infections: a quasi-experimental controlled study. JAMA Intern Med 2016; 176 (06) 796-804
    CrossrefPubMedGoogle Scholar
  • 100 Janarthanan S, Ditah I, Adler DG, Ehrinpreis MN. Clostridium difficile-associated diarrhea and proton pump inhibitor therapy: a meta-analysis. Am J Gastroenterol 2012; 107 (07) 1001-1010
    CrossrefPubMedGoogle Scholar
  • 101 Barletta JF, El-Ibiary SY, Davis LE, Nguyen B, Raney CR. Proton pump inhibitors and the risk for hospital-acquired Clostridium difficile infection. Mayo Clin Proc 2013; 88 (10) 1085-1090
    CrossrefPubMedGoogle Scholar
  • 102 Naggie S, Miller BA, Zuzak KB. , et al. A case-control study of community-associated Clostridium difficile infection: no role for proton pump inhibitors. Am J Med 2011; 124 (03) 276.e1-276.e7
    CrossrefPubMedGoogle Scholar
  • 103 Johnston BC, Ma SS, Goldenberg JZ. , et al. Probiotics for the prevention of Clostridium difficile-associated diarrhea: a systematic review and meta-analysis. Ann Intern Med 2012; 157 (12) 878-888
    PubMedGoogle Scholar
  • 104 McFarland LV. Probiotics for the primary and secondary prevention of C. difficile infections: a meta-analysis and systematic review. Antibiotics (Basel) 2015; 4 (02) 160-178
    CrossrefPubMedGoogle Scholar
  • 105 Goldenberg JZ, Yap C, Lytvyn L. , et al. Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children. Cochrane Database Syst Rev 2017; 12: CD006095
    PubMedGoogle Scholar
  • 106 Evans CT, Johnson S. Prevention of Clostridium difficile infection with probiotics. Clin Infect Dis 2015; 60 (Suppl. 02) S122-S128
    CrossrefPubMedGoogle Scholar
  • 107 Sadahiro S, Suzuki T, Tanaka A. , et al. Comparison between oral antibiotics and probiotics as bowel preparation for elective colon cancer surgery to prevent infection: prospective randomized trial. Surgery 2014; 155 (03) 493-503
    CrossrefPubMedGoogle Scholar
  • 108 Barker AK, Ngam C, Musuuza JS, Vaughn VM, Safdar N. Reducing Clostridium difficile in the inpatient setting: a systematic review of the adherence to and effectiveness of C. difficile prevention bundles. Infect Control Hosp Epidemiol 2017; 38 (06) 639-650
    CrossrefPubMedGoogle Scholar
  • 109 Louh IK, Greendyke WG, Hermann EA. , et al. Clostridium difficile infection in acute care hospitals: systematic review and best practices for prevention. Infect Control Hosp Epidemiol 2017; 38 (04) 476-482
    CrossrefPubMedGoogle Scholar
  • 110 Leav BA, Blair B, Leney M. , et al. Serum anti-toxin B antibody correlates with protection from recurrent Clostridium difficile infection (CDI). Vaccine 2010; 28 (04) 965-969
    CrossrefPubMedGoogle Scholar
  • 111 Bézay N, Ayad A, Dubischar K. , et al. Safety, immunogenicity and dose response of VLA84, a new vaccine candidate against Clostridium difficile, in healthy volunteers. Vaccine 2016; 34 (23) 2585-2592
    CrossrefPubMedGoogle Scholar
  • 112 de Bruyn G, Saleh J, Workman D. , et al; H-030-012 Clinical Investigator Study Team. Defining the optimal formulation and schedule of a candidate toxoid vaccine against Clostridium difficile infection: a randomized Phase 2 clinical trial. Vaccine 2016; 34 (19) 2170-2178
    CrossrefPubMedGoogle Scholar
  • 113 Sheldon E, Kitchin N, Peng Y. , et al. A phase 1, placebo-controlled, randomized study of the safety, tolerability, and immunogenicity of a Clostridium difficile vaccine administered with or without aluminum hydroxide in healthy adults. Vaccine 2016; 34 (18) 2082-2091
    CrossrefPubMedGoogle Scholar
  • 114 Gerding DN, Meyer T, Lee C. , et al. Administration of spores of nontoxigenic Clostridium difficile strain M3 for prevention of recurrent C. difficile infection: a randomized clinical trial. JAMA 2015; 313 (17) 1719-1727
    CrossrefPubMedGoogle Scholar
  • 115 Roberts T, Kokai-Kun JF, Coughlin O. , et al. Tolerability and pharmacokinetics of SYN-004, an orally administered β-lactamase for the prevention of Clostridium difficile-associated disease and antibiotic-associated diarrhea, in two phase 1 studies. Clin Drug Investig 2016; 36 (09) 725-734
    CrossrefPubMedGoogle Scholar
  • 116 Kokai-Kun JF, Roberts T, Coughlin O. , et al. The Oral beta-Lactamase SYN-004 (Ribaxamase) Degrades Ceftriaxone Excreted into the Intestine in Phase 2a Clinical Studies. Antimicrob Ag Chemother 2017; 61 (03) pii:e02197-e02216
    PubMedGoogle Scholar
  • 117 Ray AJ, Deshpande A, Fertelli D. , et al. A Multicenter Randomized Trial to Determine the Effect of an Environmental Disinfection Intervention on the Incidence of Healthcare-Associated Clostridium difficile Infection. Infect Control Hosp Epidemiol 2017; 38 (07) 777-783
    CrossrefPubMedGoogle Scholar
  • 118 Shea KM, Hobbs ALV, Jaso TC. , et al. Effect of a Health Care System Respiratory Fluoroquinolone Restriction Program To Alter Utilization and Impact Rates of Clostridium difficile Infection. Antimicrob Agents Chemother 2017; 61 (06) e00125-17
    CrossrefPubMedGoogle Scholar
  • 119 Ali S, Muzslay M, Wilson APR. Comparison of two whole-room ultraviolet irradiation systems for enhanced disinfection of contaminated hospital patient rooms. J Hosp Infect 2017; 97 (02) 180-184
    CrossrefPubMedGoogle Scholar
  • 120 Azab M, Doo L, Elmofti Y. et al. Comparison of the Hospital-Acquired Clostridium difficile Infection Risk of Using Proton Pump Inhibitors versus Histamine-2 Receptor Antagonists for Prophylaxis and Treatment of Stress Ulcers: A Systematic Review and Meta-Analysis. Gut Liver 2017; 11 (06) 781-788
    CrossrefPubMedGoogle Scholar
  • 121 Arriola V, Tischendorf J, Musuuza J. , et al. Assessing the Risk of Hospital-Acquired Clostridium difficile Infection with Proton Pump Inhibitor Use: A Meta-Analysis. Infect Control Hosp Epidemiol 2016; 37 (12) 1408-1417
    CrossrefPubMedGoogle Scholar
  • 122 Pozzoni P, Riva A, Bellatorre AG. , et al. Saccharomyces boulardii for the prevention of antibiotic-associated diarrhea in adult hospitalized patients: a single-center, randomized, double-blind, placebo-controlled trial. Am J Gastroenterol 2012; 107 (06) 922-931
    CrossrefPubMedGoogle Scholar